Advanced Specialty Research/ ID # 610 — Nampa, Idaho

Advanced Specialty Research/ ID # 610 is a clinical research site located in Nampa, Idaho, United States 83687.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Advanced Specialty Research/ ID # 610 has participated in 2 clinical trials.

Therapeutic areas: Endometriosis.

Sponsors: Kissei Pharmaceutical Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Nampa

Browse all research sites in Idaho · View every site in Nampa

• Saint Luke's Cancer Institute - Nampa
• Saint Alphonsus Cancer Care Center-Nampa
• Saint Alphonsus Medical Center Nampa
• Saint Luke's Mountain States Tumor Institute - Nampa
• GSK Investigational Site
• ASR,LLC
• Saltzer Medical Group
• Research Site
• Saint Luke's Mountain States Tumor Institute
• Saltzer Health
• Saltzer Medical Group Research
• Novo Nordisk Investigational Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Advanced Specialty Research/ ID # 610?

Advanced Specialty Research/ ID # 610 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Advanced Specialty Research/ ID # 610 conducted?

Advanced Specialty Research/ ID # 610 has 2 clinical trials on record. Their work covers Endometriosis.

Is Advanced Specialty Research/ ID # 610 accredited by Crixeo Clinical Trials?

Advanced Specialty Research/ ID # 610 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Advanced Specialty Research/ ID # 610?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.